A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Clinical trial NCT02524197 · COMPLETED
Trial details
- NCT number
- NCT02524197
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-01-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.